Obstet Gynecol Sci.  2016 May;59(3):208-213. 10.5468/ogs.2016.59.3.208.

A clinical study on the trocar-guided mesh repair system for pelvic organ prolapse surgery

• Bak SG
• Moon JB
• Hong SK
• Kim KJ
• Kim KA
• Lee JH

• KMID: 2351786
• DOI: http://doi.org/10.5468/ogs.2016.59.3.208

Abstract

OBJECTIVE
To evaluate the complication and recurrence rates in patients undergoing trocar-guided mesh implant for pelvic organ prolapse (POP) treatment.
METHODS
A retrospective study was performed based on the medical records of patients who had undergone mesh implant by one surgeon from May 2006 to August 2013 at the Presbyterian Medical Center in Korea. We evaluated perioperative complications such as bladder injury, mesh exposure, urinary symptoms, infections, and chronic pelvic pain. Recurrence was defined as a POP-quantification system stage ≥II or any symptomatic prolapse.
RESULTS
Sixty-seven patients were evaluated, and the mean age of patients was 65.4±7.2 years. Stage ≥III POP-quantification Ba was noted in 61 patients (91%). Intraoperative complications included three cases of bladder injury (4.5%). The mean follow-up period was 44.1±7.9 months. Postoperative complications occurred in seven women (10.5%): four cases of urinary symptoms (6%), two cases of infections (3%), and one case of chronic pelvic pain (1.5%). Mesh exposure did not occur (0%). Prolapse recurrence was reported in five patients (7.5%).
CONCLUSION
Based on our operational result, the trocar-guided mesh implant seems to provide safe and effective outcomes.

Keyword

Complications; Pelvic organ prolapse; Recurrence; Surgical mesh

MeSH Terms

Female
Follow-Up Studies
Humans
Intraoperative Complications
Korea
Medical Records
Pelvic Organ Prolapse*
Pelvic Pain
Postoperative Complications
Prolapse
Protestantism
Recurrence
Retrospective Studies
Surgical Mesh
Urinary Bladder

Reference

1. Wiener JM, Tilly J. Population ageing in the United States of America: implications for public programmes. Int J Epidemiol. 2002; 31:776–781.

2. Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008; 300:1311–1316.

3. Jelovsek JE, Maher C, Barber MD. Pelvic organ prolapse. Lancet. 2007; 369:1027–1038.

4. Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997; 89:501–506.

5. Mechanic D. The changing elderly population and future health care needs. J Urban Health. 1999; 76:24–38.

6. van Raalte H, Lucente V, Haff R, Murphy M. Prolift: an innovative delivery system for transvaginal placement of synthetic grafts for the repair of pelvic organ prolapsed. J Pelvic Med Surg. 2007; 13:351–360.

7. van Raalte HM, Lucente VR, Molden SM, Haff R, Murphy M. One-year anatomic and quality-of-life outcomes after the Prolift procedure for treatment of posthysterectomy prolapse. Am J Obstet Gynecol. 2008; 199:694.e1–694.e6.

8. Jambusaria LH, Murphy M, Lucente VR. One-year functional and anatomic outcomes of robotic sacrocolpopexy versus vaginal extraperitoneal colpopexy with mesh. Female Pelvic Med Reconstr Surg. 2015; 21:87–92.

9. Persu C, Chapple CR, Cauni V, Gutue S, Geavlete P. Pelvic Organ Prolapse Quantification System (POP-Q): a new era in pelvic prolapse staging. J Med Life. 2011; 4:75–81.

10. Ouzaid I, Hermieu JF, Misraa V, Gosseine PN, Ravery V, Delmas V. Transvaginal repair of genital prolapse using the Prolift technique: a prospective study. Prog Urol. 2010; 20:578–583.

11. US Food and Drug Administration. Update on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapsed: FDA-Safety Communication [Internet]. Silver Spring (MD): US Food and Drug Administration;2011. cited 2016 Mar 17. Available from: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm.

12. Marschke J, Hengst L, Schwertner-Tiepelmann N, Beilecke K, Tunn R. Transvaginal single-incision mesh reconstruction for recurrent or advanced anterior vaginal wall prolapse. Arch Gynecol Obstet. 2015; 291:1081–1087.

13. Altman D, Vayrynen T, Engh ME, Axelsen S, Falconer C. Nordic Transvaginal Mesh Group. Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse. N Engl J Med. 2011; 364:1826–1836.

14. Maher CM, Feiner B, Baessler K, Glazener CM. Surgical management of pelvic organ prolapse in women: the updated summary version Cochrane review. Int Urogynecol J. 2011; 22:1445–1457.

15. Moore RD, Mitchell GK, Miklos JR. Single-incision vaginal approach to treat cystocele and vault prolapse with an anterior wall mesh anchored apically to the sacrospinous ligaments. Int Urogynecol J. 2012; 23:85–91.

16. Peterson TV, Karp DR, Aguilar VC, Davila GW. Primary versus recurrent prolapse surgery: differences in outcomes. Int Urogynecol J. 2010; 21:483–488.

17. Maher C, Baessler K. Surgical management of anterior vaginal wall prolapse: an evidencebased literature review. Int Urogynecol J Pelvic Floor Dysfunct. 2006; 17:195–201.

18. Miedel A, Tegerstedt G, Morlin B, Hammarstrom M. A 5-year prospective follow-up study of vaginal surgery for pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2008; 19:1593–1601.

19. Kozal S, Ripert T, Bayoud Y, Menard J, Nicolacopoulos I, Bednarzyck L, et al. Morbidity and functional mid-term outcomes using Prolift pelvic floor repair systems. Can Urol Assoc J. 2014; 8:E605–E609.

20. Judd JP, Siddiqui NY, Barnett JC, Visco AG, Havrilesky LJ, Wu JM. Cost-minimization analysis of robotic-assisted, laparoscopic, and abdominal sacrocolpopexy. J Minim Invasive Gynecol. 2010; 17:493–499.

21. Halaska M, Maxova K, Sottner O, Svabik K, Mlcoch M, Kolarik D, et al. A multicenter, randomized, prospective, controlled study comparing sacrospinous fixation and transvaginal mesh in the treatment of posthysterectomy vaginal vault prolapse. Am J Obstet Gynecol. 2012; 207:301.e1–301.e7.

22. Vollebregt A, Fischer K, Gietelink D, van der Vaart CH. Primary surgical repair of anterior vaginal prolapse: a randomised trial comparing anatomical and functional outcome between anterior colporrhaphy and trocar-guided transobturator anterior mesh. BJOG. 2011; 118:1518–1527.

23. El-Khawand D, Wehbe SA, O'Hare PG 3rd, Arunachalam D, Vakili B. Risk factors for vaginal mesh exposure after mesh-augmented anterior repair: a retrospective cohort study. Female Pelvic Med Reconstr Surg. 2014; 20:305–309.

24. Murphy M, Holzberg A, van Raalte H, Kohli N, Goldman HB, Lucente V, et al. Time to rethink: an evidence-based response from pelvic surgeons to the FDA Safety Communication. Update on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse. Int Urogynecol J. 2012; 23:5–9.

25. Kasyan G, Abramyan K, Popov AA, Gvozdev M, Pushkar D. Mesh-related and intraoperative complications of pelvic organ prolapse repair. Cent European J Urol. 2014; 67:296–301.

26. Nussler E, Kesmodel US, Lofgren M, Nussler EK. Operation for primary cystocele with anterior colporrhaphy or non-absorbable mesh: patient-reported outcomes. Int Urogynecol J. 2015; 26:359–366.

27. Papcun P, Krizko M Jr, Spodniakova B, Redecha M, Gabor M, Ferianec V, et al. Long term follow-up of the patients with pelvic organ prolapse after the mesh implantation using strict indication criteria. Bratisl Lek Listy. 2014; 115:287–291.

28. Stepanian AA, Miklos JR, Moore RD, Mattox TF. Risk of mesh extrusion and other mesh-related complications after laparoscopic sacral colpopexy with or without concurrent laparoscopic-assisted vaginal hysterectomy: experience of 402 patients. J Minim Invasive Gynecol. 2008; 15:188–196.

29. De Ridder D. Should we use meshes in the management of vaginal prolapse? Curr Opin Urol. 2008; 18:377–382.

30. Firoozi F, Ingber MS, Moore CK, Vasavada SP, Rackley RR, Goldman HB. Purely transvaginal/perineal management of complications from commercial prolapse kits using a new prostheses/grafts complication classification system. J Urol. 2012; 187:1674–1679.